[ad_1]
To validate their results, team members worked with the European Organization for Cancer Research and Treatment.
In a press release sent jointly by the German Cancer Research Center and the University of Heidelberg, Kickingereder said that this technique improved by 36% the reliability of the manual evaluation of treatment.
The advance of AI is already tested in a clinical trial. At the National Center for Tumor Diseases in Heidelberg, researchers are incorporating it into their work to improve the treatment of patients with glioblastoma.
The co-author of the study, Klaus Maier Hein, said the team hoped to eventually adopt radiological diagnostic technology for other diseases affecting or affecting the brain, such as multiple sclerosis.
Source link
